Pathology Department and Pathology Teaching and Research Office of the First Affiliated Hospital of Chongqing Medical University, established in 1956, originated from the relocation of some pathology experts from the School of Medicine of Fudan University (formerly Shanghai First Medical College). After decades of development, it has become a professional pathology academic group integrating medical education and research, with a mature talent pool. In the "Fudan Version of China Hospital Specialty Reputation Ranking," it has consistently ranked third in the southwestern region for multiple years.
The department currently has 10 professors (including 3 doctoral supervisors), 15 associate professors, 12 lecturers, and 46 laboratory technicians, including 7 with overseas study backgrounds who have studied in the United States, Australia, the United Kingdom, Japan, and other countries. Many have held positions in various academic organizations, including as members of the Chinese Medical Association Pathology Branch Committee, Youth Committee members, Chinese Medical Doctor Association Pathology Physician Branch Committee members, Vice Chairman of the Chinese Medical Equipment Association Pathology Equipment Branch, members of the Chinese Medical Association Breast Disease Study Group, Chinese Society of Clinical Oncology Tumor Pathology Professional Committee members, Chinese Anti-Cancer Association Tumor Pathology Committee members, Vice Chairman of the Chongqing Pathology Committee, Vice Chairman of the Chongqing Medical Doctor Association Pathology Physician Branch, Academic and Technical Leaders of Chongqing, Director of Chongqing Clinical Pathology Quality Control Center, Expert in Medical Accident Identification of the Chinese Medical Association, and Expert in Medical Accident Identification of Chongqing, among others.
The department is equipped with advanced and complete facilities, including conventional pathology, immunohistochemistry, special staining, immunofluorescence, ultrastructural pathology, molecular pathology, and other technical means. It conducts routine clinical pathological biopsy diagnosis, intraoperative frozen section rapid diagnosis, exfoliative cytological diagnosis, pathological autopsy examinations, and has established advanced molecular pathology technology platforms such as FISH and high-throughput sequencing in the Chongqing region, providing pathological diagnostic services for precise diagnosis and personalized treatment of diseases. Currently, the department's annual volume of routine clinical pathological diagnoses has exceeded 100,000 cases, and intraoperative frozen rapid diagnoses exceed 12,000 cases annually, ranking first among major hospitals in Chongqing.
The department has strong technical strength. In 2010, it was approved as the "Chongqing Clinical Pathology Quality Control Center" attached unit, responsible for the supervision and guidance of clinical pathology medical quality control in Chongqing. In 2011, it became a provincial-level remote pathology consultation center designated by the Ministry of Health, undertaking difficult pathology consultation work from the southwest region and even the whole country, with approximately 7,000 cases annually. In 2020, it became the "Chongqing Pathological Diagnosis Clinical Medical Research Center," gradually establishing an important platform for the transformation of basic scientific exploration and cutting-edge technological achievements into clinical practice.
The department has established a complete training system from undergraduate education to master's, doctoral, and postdoctoral levels, accepting more than a hundred pathology fellows from across the country. Since being approved as a "Clinical Pathology Specialty Base" by the National Health Commission in 2016, it has trained dozens of specialized talents in clinical pathology. The department's course "Pathology" was successfully selected as a national first-class undergraduate course, and the graduate course "Molecular Pathology" was among the first batch of "High-quality Graduate Education Courses" in Chongqing. The department is committed to reforming teaching methods, establishing a digital database of standardized clinical pathology bases and a virtual network platform for pathological laboratory courses, achieving comprehensive digitization of pathological laboratory teaching. It has won the Chongqing Teaching Achievement Award, edited or participated in the editing of more than 30 pathology and related textbooks, and received titles such as "National Excellent Teacher," "Most Beautiful Teacher" in Chongqing, and "Chongqing Famous Teacher."
The department adheres to promoting disciplinary development through scientific research. It has currently formed two stable research directions: tumor pathology and neuropathology. In the past three years, it has undertaken 26 national, provincial, and ministerial-level natural science funds and published more than 100 academic papers in domestic and foreign journals. Among them, there are over 20 papers with an impact factor exceeding 10 and over 30 papers with an impact factor exceeding 5, and it has won two Chongqing Science and Technology Achievement Awards.
The department actively engages in international exchanges and cooperation. Returned overseas personnel have established long-term scientific research and pathological diagnostic connections with institutions such as the University of Chicago and MD Anderson Cancer Center in the United States. Sir Ian Fraser, the inventor of the cervical cancer vaccine, chairman of the Australian Cancer Society, and nominee for the Nobel Prize in Medicine, led a delegation to visit and inspect the department. The strong technical strength and complete experimental equipment of the pathology department received praise from Sir Ian and his team, and long-term exchanges and cooperation have been established with the clinical trial project related to HPV virus led by Sir Ian Fraser.
Address: Shangyi Building, Yuanjiagang Campus, Chongqing Medical University, No. 1 Medical University Road, Chongqing
Contact number: 023-68485789